WallStreetZenWallStreetZen

NASDAQ: ANGN
Angion Biomedica Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ANGN stock forecasts and price targets.

Forecast return on equity

Is ANGN forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.95%

Forecast return on assets

Is ANGN forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

ANGN revenue growth forecast

How is ANGN forecast to perform vs Biotechnology companies and vs the US market?
Company
226.47%
Industry
39.96%
Market
8.44%
ANGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ANGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ANGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANGN$1.00N/AN/A
HARP$0.80$4.83+504.13%Buy
ABIO$2.11N/AN/A
IMMX$2.04$14.00+586.27%Strong Buy
VTGN$0.13N/AN/A

Angion Biomedica Stock Forecast FAQ

What is ANGN's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ANGN) forecast ROE is N/A, which is considered weak.

If you're new to stock investing, here's how to buy Angion Biomedica stock.

What is ANGN's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ANGN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.